Showing results (311-320 of 4,129) with videos related to
Sort By:
Pageof 413
Respirology (Carlton, Vic.)|December 28, 1999
Characterization of immunoglobulin binding factor in sputum from patients with chronic airway diseasesW Ichikawa, F Ogushi, K Tani, et al.Clinical and Experimental Immunology|April 1, 1993
Augmentation by transferrin of IL-2-inducible killer activity and perforin production of human CD8+ T cellsA Nakamura, S Sone, R Nabioullin, et al.AJR. American Journal of Roentgenology|January 1, 1980
Normal anatomy of thymus and anterior mediastinum by pneumomediastinographyS Sone, T Higashihara, S Morimoto, et al.Cancer Chemotherapy and Pharmacology|June 5, 1999
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient miceS Sone, S Yano, M Hanibuchi, et al.Kaku Igaku. the Japanese Journal of Nuclear Medicine|August 1, 1992
[A new polar map to quantify reversible area by myocardial 201Tl single photon emission computed tomography and clinical application to patients before and after percutaneous transluminal coronary angioplasty]F Nakanishi, T Kasuga, S Sone, et al.Japanese Journal of Clinical Oncology|December 1, 1991
Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy GroupH Bando, Y Takishita, T Ogura, et al.Japanese Journal of Cancer Research : Gann|December 1, 1989
Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusionsH Yanagawa, S Sone, A Nii, et al.Cancer Research|December 1, 1985
Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytesI Saiki, S Sone, W E Fogler, et al.Carcinogenesis|December 12, 1997
Allelotype and replication error phenotype of small cell lung carcinomaM Kawanishi, T Kohno, T Otsuka, et al.Oncology Research|December 23, 1999
Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancerP Parajuli, S Yano, Y Nishioka, et al.Pageof 413